Clinical and social outcomes of adolescent self harm: population based birth cohort study. by Mars, B, Heron, J, Crane, C, Hawton, K, Lewis, G, Macleod, J, Tilling, K, Gunnell, D

“…MAIN OUTCOME MEASURES: Mental health problems (depression and anxiety disorder), assessed using the clinical interview schedule-revised at age 18 years, self reported substance use (alcohol, cannabis, cigarette smoking, and illicit drugs) at age 18 years, educational attainment at age 16 and 19 years, occupational outcomes at age 19 years, and self harm at age 21 years. …”

Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment by Yee, Anne, Loh, Huai Seng, Danaee, Mahmoud, Riahi, Shahrzad, Ng, Chong Guan, Sulaiman, Ahmad Hatim

“…There were no significant associations with age; Opiate Treatment Index Q scores for alcohol, heroin, stimulant, tobacco, or cannabis use and social functioning domain; education levels; hepatitis C status; and severity of depression. …”

Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10-14 year-olds: a pragmatic randomised controlled trial by Segrott, J, Gillespie, D, Lau, M, Holliday, J, Murphy, S, Foxcroft, D, Hood, K, Scourfield, J, Phillips, C, Roberts, Z, Rothwell, H, Hurlow, C, Moore, L

“…Secondary outcomes examined alcohol/tobacco/substance behaviours including: cannabis use; weekly smoking (validated by salivary cotinine measures); age of alcohol initiation; frequency of drinking >5 drinks in a row; frequency of different types of alcoholic drinks; alcohol-related problems. …”

Development of an educational module against tramadol abuse and its effectiveness among youths in Benue State, Nigeria by Orfega, Zwawua

“…Tramadol abuse among Nigerian youths has reached a worrisome level, with a projection to surpass the rate of cannabis abuse. Despite this, community educational modules on drug addiction are non-existent. …”
Get full text

12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study by De Giorgi, R, Koychev, I, Adler, A, Cowen, P, Harmer, C, Harrison, P

“…Using Cox regression analysis, we compared the risks of 22 neurological and psychiatric outcomes within one year since the index prescription: encephalitis, parkinsonism, cognitive deficit, dementia, epilepsy/seizure, migraine, insomnia, nerve disorder, myoneural junction/muscle disease, intracranial haemorrhage, ischaemic stroke, alcohol misuse, opioid misuse, cannabis misuse, stimulants misuse, nicotine misuse, psychosis, bipolar disorder, depression, anxiety, obsessive-compulsive disorder, and suicidality. …”

Effects of endogenous cannabinoids and related substances on electrical activity and contraction in cardiac ventricular muscle by Bolton, EL

“…Anandamide is an endogenous cannabinoid, ('endocannabinoid'), with similar properties to δ⁹-tetrahydrocannabinol (δ⁹-THC), the primary active constituent of Cannabis sativa. These compounds have widespread physiological effects through actions at cannabinoid CB₁ and CB₂ receptors, which are negatively coupled to adenylyl cyclases and are expressed in cardiac muscle. …”

Risk factors for violent behaviour in psychotic disorders: substance use and cognition by Lamsma, J

“…Problematic and nonproblematic use of alcohol, cannabis, stimulants, depressants and hallucinogens at any point in life were ascertained using the Composite International Diagnostic Interview-Substance Abuse Module. …”

A smartphone attention bias app for individuals with addictive disorders : feasibility and acceptability study by Zhang, Melvyn, Ying, Jiangbo, Amron, Syidda B., Mahreen, Zaakira, Song, Guo, Fung, Daniel Shuen Sheng, Smith, Helen Elizabeth

“…Of the recruited participants, 6 participants were diagnosed with alcohol dependence; 17, with opioid dependence; 2, with cannabis dependence; and 5, with stimulant dependence. …”
Get full text

Treatments for fatigue in multiple sclerosis: a rapid and systematic review. by Brañas, P, Jordan, R, Fry-Smith, A, Burls, A, Hyde, C

“…This is the main element of initial clinical management and no rigorous research of its effectiveness was identified. (2) Drugs (amantadine, pemoline, potassium-channel blockers and antidepressants). (3) Training, rehabilitation and devices (cooling vests and electromagnetic fields). (4) Alternative therapies (bee venom, cannabis, acupuncture/acupressure and yoga). Only two drugs, amantadine and pemoline, met the criteria for full systematic review. …”

Evaluating the rediscovery process as a treatment programme for a range of substance use disorders by Parker, Phil

“…First, to evaluate the effect of the TRP on substance use, flourishing, impulsivity and recovery capital, a preliminary pilot study using a randomised wait-list controlled structure was conducted. 72 participants who had been formally diagnosed with single and poly-drug use issues, including, alcohol, opiate, cocaine, crack, cannabis and amphetamine were assigned to either immediately receive the intervention or to wait for the treatment, providing a wait-list control arm. …”
Get full text

Properties of three-layer particleboards made from kenaf (Hibiscus cannabinus L.) and rubberwood (Hevea brasiliensis) by A. H., Juliana, M. T., Paridah, U. M. K., nwar

“…Rubberwood particles were used in the face layers while kenaf (Hibiscus cannabi�nus L.) particles were used in the middle of the panels of the particleboards. …”
Get full text

Cannabinoids in models of chronic inflammatory conditions by Mechoulam, R, Sumariwalla, P, Feldmann, M, Gallily, R

“…Cannabis sativa has been used as an anti-inflammatory plant for millennia. …”